Operating Lease, Right-of-Use Asset in USD of BICYCLE THERAPEUTICS PLC from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bicycle Therapeutics Plc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2019 to Q3 2025.
  • Bicycle Therapeutics Plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4.56M, a 49.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $4.56M -$4.53M -49.8% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $5.81M -$5.13M -46.9% 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $6.71M -$5.31M -44.2% 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $7.67M -$5.5M -41.7% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $9.09M -$5.51M -37.7% 30 Sep 2024 10-Q 31 Oct 2024
Q2 2024 $10.9M -$5.09M -31.8% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $12M -$6.7M -35.8% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $13.2M -$489K -3.58% 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 $14.6M +$1.11M +8.25% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $16M +$946K +6.28% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $18.7M +$1.97M +11.8% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $13.7M -$1.01M -6.87% 31 Dec 2022 10-K 20 Feb 2024
Q3 2022 $13.5M +$10.2M +315% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $15.1M +$11.5M +327% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $16.8M +$13M +350% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $14.7M +$13.4M +1037% 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $3.25M +$1.79M +122% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $3.53M +$1.9M +117% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $3.72M +$1.91M +105% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $1.29M -$766K -37.3% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $1.46M -$718K -33% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $1.63M -$759K -31.8% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $1.82M 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $2.06M 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 $2.18M 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $2.39M 30 Jun 2019 10-Q 08 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.